3.07
-0.07 (-2.23%)
| Previous Close | 3.14 |
| Open | 3.15 |
| Volume | 1,274,451 |
| Avg. Volume (3M) | 2,079,163 |
| Market Cap | 4,560,641 |
| Price / Book | 0.400 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -1.12 |
| Total Debt/Equity (MRQ) | 1.56% |
| Current Ratio (MRQ) | 1.75 |
| Operating Cash Flow (TTM) | -4.57 M |
| Levered Free Cash Flow (TTM) | -3.45 M |
| Return on Assets (TTM) | -52.23% |
| Return on Equity (TTM) | -139.17% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Clearmind Medicine Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | 3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | 0.20 |
|
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company’s intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 2.80% |
| % Held by Institutions | 10.91% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| HRT FINANCIAL LP | 3.20 | 3.34 | 1,933,861 | 6,156,828 |
| Aggregate Net Quantity | 1,933,861 | |||
| Aggregate Net Value ($) | 6,156,828 | |||
| Aggregate Avg. Buy ($) | 3.20 | |||
| Aggregate Avg. Sell ($) | 3.34 | |||
| Insider Range ($) | ||||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 11 Jun 2026 | Sell (-) | 225,191 | 3.34 | 752,138 | |
| HRT FINANCIAL LP | 10 Jun 2026 | Buy (+) | 2,159,052 | 3.20 | 6,908,966 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |